ArticleAnnals of translational medicine2022

MiR-95-3p acts as a prognostic marker and promotes cervical cancer progression by targeting VCAM1.

Sijie Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.